Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves’ orbitopathy

The combination therapy demonstrates significant effectiveness in treating patients with GO who experienced severe ocular inflammation and have previous GPT failure. Noticeable improvement is observed as early as one month after initiating radiation therapy, and patients with more severe inflammatory states showes greater benefit from the treatment.